Examine the progress in detecting and treating this neurodegenerative disease, which, after cancer and heart disease, takes more lives each year than any other illness.
Discover who is at greatest risk and hear about new ways to treat or possibly prevent Alzheimer’s disease, including the TTAP Method™ (Therapeutic Thematic Arts Programming for the Older Population).
Do you have questions for either guest? Submit them on the 92Y Facebook page and we will forward them for consideration during the Q&A. And don't forget to share the link with any interested friends on Twitter and Facebook!
Brief Biography
Mary Sano, PhD, is a neuropsychologist, professor of psychiatry and the director of Alzheimer’s disease research at Mount Sinai School of Medicine.
Linda Levine Madori, PhD, is a professor at St. Thomas Aquinas College and the creator of the Therapeutic Thematic Arts Programming for the Older Population (TTAP Method™).
Do you have questions about Alzheimer’s disease? Now's your chance to ask the experts.
Alzheimer’s disease is the most common form of dementia, and the sixth leading cause of death across all ages in the United States. The Alzheimer’s Association reports that one out of eight Americans over the age of 65 has Alzheimer’s disease, and the total number of dementia-related illnesses are expected to double by 2050, being driven primarily by the aging Baby Boomer population and longer life expectancy rates [PDF].
Dr. Mary Sano, Director of Alzheimer’s Disease Research at Mount Sinai School of Medicine, and Dr. Linda Levine Madori, professor at St. Thomas Aquinas College and creator of the Therapeutic Thematic Arts Programming for the Older Population (TTAP Method™), will visit 92Ynd Street Y on November 1 to discuss new ways to treat or prevent Alzheimer’s, including the TTAP Method™ (Therapeutic Thematic Arts Programming for the Older Population).
Submit your questions for either speaker on the 92Y Facebook page. We will forward them for consideration during the Q&A. And don't forget to share the link with any interested friends on Twitter and Facebook!